Next Article in Journal
Previous Article in Journal
J. Pers. Med. 2012, 2(3), 71-76; doi:10.3390/jpm2030071
Case Report

Clinical Utility of Gene Expression Profiling Data for Clinical Decision-Making Regarding Adjuvant Therapy in Early Stage, Node-Negative Breast Cancer: A Case Report

1,* , 2
, 1
, 3
 and 1
Received: 16 August 2012; Accepted: 4 September 2012 / Published: 10 September 2012
View Full-Text   |   Download PDF [647 KB, uploaded 10 September 2012]   |   Browse Figures
Abstract: Breast cancer is the most common malignancy among women in the United States with the second highest incidence of cancer-related death following lung cancer. The decision-making process regarding adjuvant therapy is a time intensive dialogue between the patient and her oncologist. There are multiple tools that help individualize the treatment options for a patient. Population-based analysis with Adjuvant! Online and genomic profiling with Oncotype DX are two commonly used tools in patients with early stage, node-negative breast cancer. This case report illustrates a situation in which the population-based prognostic and predictive information differed dramatically from that obtained from genomic profiling and affected the patient’s decision. In light of this case, we discuss the benefits and limitations of these tools.
Keywords: breast cancer; genomic profiling; medical decision-making; Oncotype DX; chemotherapy; personalized medicine breast cancer; genomic profiling; medical decision-making; Oncotype DX; chemotherapy; personalized medicine
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Schuster, S.R.; Pockaj, B.A.; Bothe, M.R.; David, P.S.; Northfelt, D.W. Clinical Utility of Gene Expression Profiling Data for Clinical Decision-Making Regarding Adjuvant Therapy in Early Stage, Node-Negative Breast Cancer: A Case Report. J. Pers. Med. 2012, 2, 71-76.

AMA Style

Schuster SR, Pockaj BA, Bothe MR, David PS, Northfelt DW. Clinical Utility of Gene Expression Profiling Data for Clinical Decision-Making Regarding Adjuvant Therapy in Early Stage, Node-Negative Breast Cancer: A Case Report. Journal of Personalized Medicine. 2012; 2(3):71-76.

Chicago/Turabian Style

Schuster, Steven R.; Pockaj, Barbara A.; Bothe, Mary R.; David, Paru S.; Northfelt, Donald W. 2012. "Clinical Utility of Gene Expression Profiling Data for Clinical Decision-Making Regarding Adjuvant Therapy in Early Stage, Node-Negative Breast Cancer: A Case Report." J. Pers. Med. 2, no. 3: 71-76.

J. Pers. Med. EISSN 2075-4426 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert